Cosmos Health reported record-breaking financial results for the third quarter of 2025, achieving the highest revenue, gross profit, and gross margin in its history.
Revenue for Q3 2025 reached $17.1 million, a 38% increase from the same period in 2024, driven by strong performance across all core business segments.
Gross profit saw a remarkable increase of 116% to $2.6 million in Q3 2025 compared to the previous year, marking the highest quarterly gross profit for the company.
Revenue Growth
Revenue for Q3 2025 reached $17.1 million, marking a significant increase of 38% from the same period in 2024.
Gross Profit Surge
Gross profit in Q3 2025 soared by 116% to $2.6 million compared to the previous year, reflecting strong operational performance.
Adjusted EBITDA Improvement
Adjusted EBITDA for Q3 2025 increased by 74%, showcasing enhanced profitability and cost management strategies.
- Cosmos Health's strong financial performance in Q3 2025 was driven by record-breaking revenue and gross profit figures, demonstrating the effectiveness of its business strategies and the success of core business segments.
- The company's increased focus on efficiency and higher-margin products led to a significant improvement in gross margin, indicating better cost controls and sales mix optimization.
Cosmos Health's exceptional results in Q3 2025 showcase its continued growth and success in the global healthcare market. With a record-breaking quarter in terms of revenue and gross profit, the company's strategic initiatives and operational performance are driving positive financial outcomes.